This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Doyle, A. Articles by Bridges, A. Search for Related Content Social Bookmarking                         What's this?

A prospective study to investigate the incidence of atherosclerotic vascular disease in patients with newly diagnosed type 2 diabetes mellitus

Renal Unit, Walton Building, Glasgow Royal Infirmary, Glasgow, G4 0SF, UK, arthur.doyle{at}gmail.com

Linda M Buchanan

Falkirk Royal Infirmary, Westburn Avenue, Falkirk, FK1 5QE, UK

Shiela Bm Reith

Stirling Royal Infirmary, Livilands, Stirling, FK8 2AU, UK

Allan Bridges

Stirling Royal Infirmary, Livilands, Stirling, FK8 2AU, UK

Type 2 diabetes is associated with premature cardiovascular disease (CVD). We examined the extent of vascular disease and modifiable risk factors in 50 sequential patients with type 2 diabetes, without a previous diagnosis of vascular disease, at their first presentation to a hospital diabetes clinic. Sixty-four per cent of patients were obese (BMI 30). Average HbA1C was 6.8% and mean total cholesterol was 5.74 mmol/L. Forty-seven per cent were hypertensive (systolic pressures 140) and 18% were current smokers.

Eighteen point four per cent of this population had ischaemic heart disease detectable by ECG and exercise ECG. Eighteen per cent had a reduced ankle: brachial pressure index and 49% had carotid atheroma by Doppler scanning.

These findings illustrate the case for aggressive primary vascular disease prevention strategies from the time of diagnosis in type 2 diabetes.

Key Words: diabetes mellitus • atherosclerosis • hypertension • hypercholesterolaemia • ischaemic heart disease.

References

• Oswald GA, Corcoran S., Yudkin JS Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984;8389:1264-7.
• Sewdarsen M., Vythilingum S., Jialal I., Becker PJ Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q J Med 1989;265:461-6.
• Colhoun HM, Dong W., Barakat MT, Mather HM, Poulter NR The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94. Diabet Med 1999;16:35-40.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;209:3015-23.
• Syvänne M., Taskinen M. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 1997;350(suppl 1):20-3.[CrossRef]
• Haffner SM, Lehto S., RonnemaaT, Pyorala K., Laakso M. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. N Engl J Med 1998;339:229-34.[Abstract/Free Full Text]
• Haffner SM The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease. Diabetes Care 1997;20:469-71.[Web of Science][Medline] [Order article via Infotrieve]
• Gu K., Cowie CC, Harris MI Diabetes and decline in heart disease mortality in US adults. JAMA 1999;281:1291-7.[Abstract/Free Full Text]
• Pyorala K., Pedersen TR, Kjekshus J., Faergeman O., Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20:614-20.[Abstract]
• Hansson L., Zanchetti A., Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rose GA, Blackburn H., Gillium RF, Prineas RJ Cardiovascular Survey Methods. 2nd ed. Geneva, Switzerland, World Health Organization, 1982. Methods. 2nd ed. Geneva, Switzerland, World Health Organization, 1982.
• 2. UKPDS 5. Characteristics of newly presenting type 2 diabetic patients: estimated insulin sensitivity and islet beta-cell function. UKPDS Study Group Diabetic Medicine 1988;5:444-8.

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 3, 155-158 (2005)
DOI: 10.1177/14746514050050030801


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Doyle, A. Articles by Bridges, A. Search for Related Content Social Bookmarking                         What's this?